Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.940
-0.050 (-2.51%)
At close: Apr 2, 2026, 4:00 PM EDT
1.920
-0.020 (-1.03%)
After-hours: Apr 2, 2026, 6:28 PM EDT
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $187.48 million as of April 2, 2026. Its market cap has increased by 111.99% in one year.
Market Cap
187.48M
Enterprise Value
71.86M
1-Year Change
111.99%
Ranking
Category
Stock Price
$1.94
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $187.48M, a decrease of -78.90%. That is a compound annual growth rate of -28.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 187.48M | 26.15% |
| Dec 31, 2025 | 148.61M | 3.22% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
| Jul 23, 2021 | 888.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nuvectis Pharma | 200.28M |
| Tonix Pharmaceuticals Holding | 197.46M |
| Elicio Therapeutics | 195.92M |
| MacroGenics | 195.12M |
| Acumen Pharmaceuticals | 194.97M |
| Jyong Biotech | 188.41M |
| Adagene | 188.05M |
| Zentalis Pharmaceuticals | 186.55M |